Technology News and Research

RSS

Evonetix places first DNA synthesis development platform at Imperial College London

External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology in preparation for customer use and commercialization.

From Evonetix 4 Oct 2023

Carol Stonham MBE, RN, MSc, Queen’s Nurse, and Policy Lead PCRS joins the Bedfont® Medical Advisory Board

Bedfont® Scientific Ltd, a leading innovator in breath analysis medical device technology, is proud to announce the addition of Carol Stonham, a highly respected and accredited respiratory healthcare expert, to its esteemed medical board.

From Bedfont® Scientific Ltd 4 Oct 2023

Particle Measuring Systems, Inc. announces acquisition of Environmental Monitoring Services Irl. Limited and EMS Particle Solutions Ltd

Particle Measuring Systems, Inc. announces the acquisition of Environmental Monitoring Services Irl. Limited and EMS Particle Solutions Ltd, and their parent company (collectively EMS); established in 1988, and headquartered in Dublin, Ireland.

From Particle Measuring Systems 4 Oct 2023

Sphere Fluidics’ Cyto-Mine system selected by FairJourney Biologics to advance cell line development workflows

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced the Cyto-Mine® platform has been selected by FairJourney Biologics, a world leading end-to-end antibody partner, providing integrated services across antibody discovery, engineering, and production, to expand its cell line development capabilities.

From Fluidic Sciences and Sphere Bio 4 Oct 2023

Ubiquigent collaborates with Imperial College London on DUB probe discovery to facilitate preclinical and clinical target engagement studies

Ubiquigent Limited (Ubiquigent), a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, today announced it is supporting a PhD student in the Institute of Chemical Biology EPSRC Centre for Doctoral Training (CDT) in Chemical Biology, at Imperial College London.

From Ubiquigent Limited 4 Oct 2023

Robotic device could revolutionize how women monitor their breast health

A device has been created that could carry out Clinical Breast Examinations (CBE).

3 Oct 2023

Robotic percutaneous coronary intervention: A review of current status and future prospects

Announcing a new article publication for Cardiovascular Innovations and Applications journal.

3 Oct 2023

NIH grant to fund development of new gene therapy platform for brain diseases

A two-phase NIH grant will fund research into a new CRISPR-based gene therapy platform that will target genetic brain diseases like Angelman syndrome and H1-4 (HIST1H1E) syndrome.

3 Oct 2023

Telestroke program improves stroke care for rural patients

Minutes matter when a patient may have had a stroke, but being far from a physician with advanced training in neurology no longer needs to be a barrier to rapid diagnosis and intervention.

3 Oct 2023

Nemours Children's Health to lead discussion on child health at HLTH

Nemours Children's Health will host the first-ever dedicated pediatric session at HLTH, the leading platform bringing together the entire health ecosystem focused on health innovation and transformation.

3 Oct 2023

Liquid biopsies can accurately detect residual disease in patients with cervical cancer, study confirms

Two liquid biopsy tests that look for the presence of human papillomavirus (HPV) in the blood accurately identified patients with a high risk of cervical cancer recurrence after the completion of chemoradiation, a new study confirms.

3 Oct 2023

Mogrify extends Series A financing to $46 million USD

Mogrify Limited (Mogrify®), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced today an additional $10 million USD closing of its Series A financing.

From Mogrify 2 Oct 2023

Evonetix unveils new branding to align with its vision for gene-length DNA synthesis

EVONETIX LTD (‘Evonetix’) today announces the introduction of new branding.

From Evonetix 2 Oct 2023

Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialization

Broken String Biosciences, a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced the expansion of its senior leadership team.

From Broken String Biosciences 2 Oct 2023

Cancer pathway process can be streamlined with the adoption of AI and automation

Medicine is a constantly evolving science where small changes can have a huge impact on the lives of patients. When it comes to a cancer diagnosis and treatment, every minute counts. According to European Commission estimates, the cancer incidence by 2040 will impact just over three million people a year.

30 Sep 2023

Autologous breast reconstruction linked to higher patient satisfaction

Women undergoing autologous breast reconstruction – in which the breast is reconstructed using the patient's own tissues– report higher satisfaction with their breasts at follow-up, compared to those undergoing implant-based reconstruction, reports a study in a special October supplement to Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

29 Sep 2023

New tau PET radiotracer shows promise for early detection of Alzheimer's disease

A new tau PET radiotracer, 18F-SNFT-1, has been found to be more effective than existing tau PET radiotracers in identifying Alzheimer's disease in its earliest stages, according to research published in the September issue of The Journal of Nuclear Medicine.

29 Sep 2023

Parasites that cause visceral leishmaniasis can infect non-immune cells, study finds

The organisms that cause visceral leishmaniasis, a potentially deadly version of the parasitic disease that most often affects the skin to cause disfiguring disease, appear to have a secret weapon, new research suggests: They can infect non-immune cells and persist in those uncommon environments.

29 Sep 2023

New recommendations to improve outcomes at US congenital heart surgery centers

A set of recommendations to address the known variation in outcomes at US congenital heart surgery centers has been endorsed by 15 collaborating societies led by the Congenital Heart Surgeons' Society (CHSS).

29 Sep 2023

Cutting-edge NanoSIMS imaging sheds light on the progression of Parkinson's disease

Parkinson's disease is a complex neurodegenerative disorder that leads to the deterioration of specific types of neurons in the brain, resulting in a number of motor and non-motor symptoms.

29 Sep 2023

Technology News and Research

Evonetix places first DNA synthesis development platform at Imperial College London

Carol Stonham MBE, RN, MSc, Queen’s Nurse, and Policy Lead PCRS joins the Bedfont® Medical Advisory Board

Particle Measuring Systems, Inc. announces acquisition of Environmental Monitoring Services Irl. Limited and EMS Particle Solutions Ltd

Sphere Fluidics’ Cyto-Mine system selected by FairJourney Biologics to advance cell line development workflows

Ubiquigent collaborates with Imperial College London on DUB probe discovery to facilitate preclinical and clinical target engagement studies

Robotic device could revolutionize how women monitor their breast health

Robotic percutaneous coronary intervention: A review of current status and future prospects

NIH grant to fund development of new gene therapy platform for brain diseases

Telestroke program improves stroke care for rural patients

Nemours Children's Health to lead discussion on child health at HLTH

Liquid biopsies can accurately detect residual disease in patients with cervical cancer, study confirms

Mogrify extends Series A financing to $46 million USD

Evonetix unveils new branding to align with its vision for gene-length DNA synthesis

Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialization

Cancer pathway process can be streamlined with the adoption of AI and automation

Autologous breast reconstruction linked to higher patient satisfaction

New tau PET radiotracer shows promise for early detection of Alzheimer's disease

Parasites that cause visceral leishmaniasis can infect non-immune cells, study finds

New recommendations to improve outcomes at US congenital heart surgery centers

Cutting-edge NanoSIMS imaging sheds light on the progression of Parkinson's disease

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News